FGC
RDY icon

Financial Gravity Companies’s Dr. Reddy's Laboratories RDY Stock Holding History

Financial Gravity Companies’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$2K Buy
+290
New +$2.04K ﹤0.01% 947
2018
Q1 		$1K Buy
150
+20
+15% +$140 ﹤0.01% 1227
2017
Q4 		$1K Buy
+130
New +$936 ﹤0.01% 1196

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Financial Gravity Companies's RDY Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Dr. Reddy's Laboratories (RDY) in Q4 2018: 290 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #947 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in RDY as recently as Q1 2018.

Financial Gravity Companies first reported a position in RDY in Q4 2017 and has held it in 3 quarters since. 146 funds tracked by Wall St. Rank hold RDY as of Q4 2018.

  • Financial Gravity Companies held 290 shares of Dr. Reddy's Laboratories worth $2K as of Q4 2018.
  • Dr. Reddy's Laboratories was a new Financial Gravity Companies position in Q4 2018.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #947 holding.
  • Financial Gravity Companies first reported a position in Dr. Reddy's Laboratories in Q4 2017 and has held it in 3 quarters since.
  • 146 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.